SCHEMBL30834852

SCHEMBL30834852

Cc1nc(S)c2[nH]cnc2n1.[Na].[Na]

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDPK1 O15530 2/20 0.40
▸ GDA Q9Y2T3 1/20 0.40
▸ ADORA3 P0DMS8 3/20 0.39
▸ ADORA1 P30542 2/20 0.39
▸ XDH P47989 2/20 0.39
▸ MAP3K5 Q99683 1/20 0.39
▸ CDK2 P24941 4/20 0.38
▸ DPP4 P27487 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ PNP P00491 1/20 0.37
▸ ADORA2A P29274 2/20 0.36
▸ CDK1 P06493 2/20 0.36
▸ CCNB1 P14635 2/20 0.36
▸ CCNA2 P20248 2/20 0.36
▸ CCNA1 P78396 2/20 0.36
▸ PIK3CA P42336 1/20 0.35
▸ MTOR P42345 1/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3857170 0.98 PDPK1 (0.41) PDPK1GDAADORA3ADORA1XDH
Thioguanine SCHEMBL9153902 0.81 PDPK1 (0.63) PDPK1GDAADORA1XDHMAP3K5
SCHEMBL5403767 0.78 CDK2 (0.41) PDPK1GDAADORA3ADORA1XDH
SCHEMBL1275417 0.78 PDPK1 (0.44) PDPK1GDAADORA3ADORA1XDH
SCHEMBL29366073 0.78 PDPK1 (0.44) PDPK1GDAADORA3ADORA1XDH
SCHEMBL30834788 0.77 CYP1A2 (0.50) PDPK1GDAADORA3ADORA1XDH
SCHEMBL29375916 0.74 PDPK1 (0.66) PDPK1GDAXDHMAP3K5CDK2
SCHEMBL19780 0.74 PDPK1 (0.66) PDPK1GDAXDHMAP3K5CDK2
SCHEMBL3002433 0.74 DPP4 (0.61) PDPK1GDAADORA3ADORA1XDH
SCHEMBL545835 0.74 PDPK1 (0.41) PDPK1GDAADORA3ADORA1XDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260114475-A1 ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME MARS, INCORPORATED (US) 2026-04-30 — — US disclosed
EP-4593631-A1 ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME Mars, Incorporated (US) 2025-08-06 — — EP disclosed
WO-2024073025-A1 ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME MARS, INCORPORATED (US) 2024-04-04 — — WO disclosed
EP-4344552-A1 ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY, AND METHODS FOR PREPARING THE SAME MARS, INCORPORATED (US) 2024-04-03 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260114475-A1 ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME PIGS, TAS2R13, CEL PDPK1 81/4885GDA 1992/4885ADORA3 1442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback